Evidence map›Paper›PMID 18439194›Full record

ReviewAcademic emergency medicine : official journal of the Society for Academic Emergency Medicine2008

Resuscitating the microcirculation in sepsis: the central role of nitric oxide, emerging concepts for novel therapies, and challenges for clinical trials.

Stephen Trzeciak, Ismail Cinel, R Phillip Dellinger, Nathan I Shapiro, Ryan C Arnold, Joseph E Parrillo, Steven M Hollenberg, Microcirculatory Alterations in Resuscitation and Shock (MARS) Investigators

Open access · bronzeAbstract readReview
In one paragraph

Review in Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed
12.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 214 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Nitric oxide: Clinical applications in critically ill patients.Nitric oxide : biology and chemistry · 2022
    Review
  19. Article
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Stephen TrzeciakDepartment of Emergency Medicine, Division of Critical Care Medicine, University of Medicine and Dentistry of New Jersey (UMDNJ)-Robert Wood Johnson Medical School at Camden, Cooper University Hospital, Camden, NJ, USA. trzeciak-stephen@cooperhealth.edu
Ismail Cinel
R Phillip Dellinger
Nathan I Shapiro
Ryan C Arnold
Joseph E Parrillo
Steven M Hollenberg
Microcirculatory Alterations in Resuscitation and Shock (MARS) Investigators
Cooper University Hospital · US

Funding

Randomized Trial of Inhaled Nitric Oxide to Augment Tissue Perfusion in SepsisK23GM083211 · NIGMS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI TRZECIAK, STEPHEN WALTER · 2008 to 2012
$679k
NIGMS NIH HHS K23 GM083211NIGMS NIH HHS K23GM083211
6 · The paper itself

Abstract

Microcirculatory dysfunction is a critical element of the pathogenesis of severe sepsis and septic shock. In this Bench-to-Bedside review, we present: 1) the central role of the microcirculation in the pathophysiology of sepsis; 2) new translational research techniques of in vivo video microscopy for assessment of microcirculatory flow in human subjects; 3) clinical investigations that reported associations between microcirculatory dysfunction and outcome in septic patients; 4) the potential role of novel agents to "rescue" the microcirculation in sepsis; 5) current challenges facing this emerging field of clinical investigation; and 6) a framework for the design of future clinical trials aimed to determine the impact of novel agents on microcirculatory flow and organ failure in patients with sepsis. We specifically focus this review on the central role and vital importance of the nitric oxide (NO) molecule in maintaining microcirculatory homeostasis and patency, especially when the microcirculation sustains an insult (as with sepsis). We also present the scientific rationale for clinical trials of exogenous NO administration to treat microcirculatory dysfunction and augment microcirculatory blood flow in early sepsis therapy.

Indexed as

Nitric OxideCardiac OutputHomeostasisHumansMicrocirculationRandomized Controlled Trials as TopicResuscitationSepsisNitric Oxide

Identifiers

PMID18439194
PMCPMC2727641
OpenAlexW1976371937

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.